groups with high risk and not appropriate to risk with cardiovascular risk (CV risk) calculator
Last reviewed 01/2018
- Framingham 1991 risk equations should not be used for people with pre-existing:
- CHD or angina
- stroke or transient ischaemic attack
- peripheral vascular disease
- Framingham risk equation should not be used for people who are already
considered at high risk of CVD because of:
- familial hypercholesterolaemia or other monogenic disorders of lipid metabolism
- diabetes
- CVD risk scores may not be appropriate as a way of assessing risk in
people who are at increased CVD risk because of underlying medical conditions
or treatments. These include people:
- treated for HIV or with antipsychotic medication
- people with autoimmune disorders such as systemic lupus erythematosus (SLE) and rheumatoid arthritis
- people taking medicines that can cause dyslipidaemia such as antipsychotic
medication, corticosteroids or immunosuppressant drugs
-
people with CKD (3)
- offer atorvastatin 20 mg for the primary or secondary prevention of
CVD to people with CKD
- increase thedose if a greater than 40% reduction in non-HDL cholesterol is not achieved and eGFR is 30 ml/min/1.73 m2 or more
- agree the use of higher doses with a renal specialist if eGFR is less than 30 ml/min/ 1.73 m2
- offer atorvastatin 20 mg for the primary or secondary prevention of
CVD to people with CKD
Rheumatoid arthritis and cardiovascular risk:
- data indicate that CVD mortality is increased by approximately 50% in RA patients compared with the general population (2)
Reference:
- (1) NICE (May 2008).Lipid modification - Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
- (2) Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D.Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies Arthritis Rheum. 2008 Dec 15;59(12):1690-7.
- (3) NICE (July 2014). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
cardiovascular (CV) risk calculator (how to use one)
hyperlipididaemia and atypical antipsychotic drugs
target cholesterol levels - primary prevention in reducing CV risk
target lipid levels - secondary prevention in reducing CV risk